Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial-Reference-Cited by-同舟云学术

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Published:2016-08 Issue:8 Volume:17 Page:1047-1060
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dearnaley David,Syndikus Isabel,Mossop Helen,Khoo Vincent,Birtle Alison,Bloomfield David,Graham John,Kirkbride Peter,Logue John,Malik Zafar,Money-Kyrle Julian,O'Sullivan Joe M,Panades Miguel,Parker Chris,Patterson Helen,Scrase Christopher,Staffurth John,Stockdale Andrew,Tremlett Jean,Bidmead Margaret,Mayles Helen,Naismith Olivia,South Chris,Gao Annie,Cruickshank Clare,Hassan Shama,Pugh Julia,Griffin Clare,Hall Emma

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions;Soerjomataram;Lancet,2012

2. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer;Wolff;Eur J Cancer,2015

3. Systematic review of hypofractionated radiation therapy for prostate cancer;Zaorsky;Cancer Treat Rev,2013

4. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014

5. High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up;Hou;J Cancer Res Clin Oncol,2015

Cited by 999 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials;Clinical and Translational Radiation Oncology;2024-11

2. Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts;Biochemical and Biophysical Research Communications;2024-10

3. Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy;Radiation Oncology;2024-09-02

4. Modelling radiobiology;Physics in Medicine & Biology;2024-09-02

5. Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study;Clinical and Translational Radiation Oncology;2024-09